We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.4%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.28B
Cap. Flow
% of AUM
5.2%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$167M |
| 2 |
Apple
AAPL
|
+$66M |
| 3 |
Microsoft
MSFT
|
+$57.3M |
| 4 |
HDFC Bank
HDB
|
+$44M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$81.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$81.3M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$45.8M |
| 4 |
Advanced Micro Devices
AMD
|
+$43.4M |
| 5 |
Meta Platforms (Facebook)
META
|
+$35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
1401
Rapport Therapeutics
RAPP
$2.27B
| $23.2K | ﹤0.01% |
+1,219
| New | +$27K |
|
|
TECX
1402
Tectonic Therapeutic
TECX
$704M
| $23.1K | ﹤0.01% |
+492
| New | +$20.8K |
|
1403
Liberty Broadband Class C
LBRDK
$5.18B
| $22.9K | ﹤0.01% |
301
-180
| -37% | -$15K |
|
1404
Omeros
OMER
$1.26B
| $22.6K | ﹤0.01% |
+1,931
| New | +$13.3K |
|
1405
Kura Oncology
KURA
$980M
| $22.5K | ﹤0.01% |
2,591
-181
| -7% | -$2.6K |
|
|
AHRT
1406
AH Realty Trust
AHRT
$507M
| $22.4K | ﹤0.01% |
2,224
-379
| -15% | -$4.12K |
|
1407
Keros Therapeutics
KROS
$226M
| $22.2K | ﹤0.01% |
1,350
-7
| -0.5% | -$364 |
|
|
ORKA
1408
Oruka Therapeutics
ORKA
$6.99B
| $22.2K | ﹤0.01% |
+1,166
| New | +$28.4K |
|
|
BLTE
1409
Belite Bio
BLTE
$6.88B
| $22.1K | ﹤0.01% |
+357
| New | +$23.5K |
|
1410
Global E Online
GLBE
$7.05B
| $22.1K | ﹤0.01% |
405
| – | – |
|
|
GRAL
1411
GRAIL Inc
GRAL
$3.11B
| $22K | ﹤0.01% |
1,120
-3
| -0.3% | -$49 |
|
1412
Envista
NVST
$4.63B
| $21.7K | ﹤0.01% |
1,130
-449
| -28% | -$8.88K |
|
1413
Entrada Therapeutics
TRDA
$294M
| $21.7K | ﹤0.01% |
+1,246
| New | +$22.6K |
|
|
CRGX
1414
DELISTED
CARGO Therapeutics
CRGX
| $21.7K | ﹤0.01% |
+1,534
| New | +$27.8K |
|
|
TIGR
1415
UP Fintech Holding
TIGR
$820M
| $21.7K | ﹤0.01% |
3,330
+220
| +7% | +$1.51K |
|
1416
Teradata
TDC
$2.53B
| $21.5K | ﹤0.01% |
680
-153
| -18% | -$4.79K |
|
|
BCYC
1417
Bicycle Therapeutics
BCYC
$280M
| $21.3K | ﹤0.01% |
1,466
+124
| +9% | +$2.66K |
|
1418
Mineralys Therapeutics
MLYS
$2.35B
| $21.3K | ﹤0.01% |
1,658
-141
| -8% | -$1.84K |
|
|
EH
1419
EHang Holdings
EH
$437M
| $21.1K | ﹤0.01% |
1,350
+53
| +4% | +$851 |
|
1420
iShares Global Infrastructure ETF
IGF
$10.7B
| $20.8K | ﹤0.01% |
41,873
-5,920
| -12% | -$320K |
|
|
INN
1421
Summit Hotel Properties
INN
$647M
| $20.5K | ﹤0.01% |
3,023
-1,176
| -28% | -$7.73K |
|
1422
Arbutus Biopharma
ABUS
$904M
| $20.3K | ﹤0.01% |
6,315
-513
| -8% | -$1.89K |
|
|
PLYM
1423
DELISTED
Plymouth Industrial REIT
PLYM
| $20.2K | ﹤0.01% |
1,140
-445
| -28% | -$8.8K |
|
1424
ACI Worldwide
ACIW
$5.36B
| $19.9K | ﹤0.01% |
383
-71
| -16% | -$3.78K |
|
1425
SITE Centers
SITC
$158M
| $19.8K | ﹤0.01% |
1,316
-8,066
| -86% | -$130K |
|
Similar funds
Mirae Asset Global Investments's Q4 2024 Portfolio in Review
As of Q4 2024, Mirae Asset Global Investments held 1,702 positions worth $24.6B, up 9% from $22.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Mirae Asset Global Investments deployed $1.28B of net new capital in Q4 2024, opening 151 new positions and adding to 731 existing holdings. Its largest new stake was Strategy Inc: 36,162 shares worth $11.8M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $81.5M trimmed.
- Mirae Asset Global Investments's largest Q4 2024 buy was Strategy Inc: 36,162 shares worth $11.8M.
- Mirae Asset Global Investments added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $167M increase.
- Mirae Asset Global Investments's biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $81.5M.
- Mirae Asset Global Investments fully exited VanEck Pharmaceutical ETF in Q4 2024, selling an estimated $23.6M.
- Mirae Asset Global Investments's ten largest holdings make up 38% of its $24.6B portfolio in Q4 2024.
- Mirae Asset Global Investments opened 151 new positions and closed 110 in Q4 2024.
- Mirae Asset Global Investments's portfolio value rose 9% quarter-over-quarter to $24.6B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.